查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553673

人工重要器官和醫療仿生市場規模、佔有率、趨勢分析報告：2024-2030 年人工器官、仿生學、地區和細分市場預測

Artificial Vital Organs And Medical Bionics Market Size, Share & Trends Analysis Report By Artificial Organs (Heart, Kidney, Liver), By Bionics (Ear Bionics, Vision Bionics, Exoskeletons), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

人工重要器官和醫學仿生學市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球人工重要器官和醫療仿生市場規模將達到701億美元，2024年至2030年複合年成長率為9.3%。

人工重要器官市場的主要成長動力包括越來越多的老年人口患有導致器官衰竭和損傷的心血管疾病和呼吸系統疾病等慢性疾病。

此外，由於先天因素、事故、兵役、工業事故等導致肢體和手臂缺陷等身體殘疾的患者數量不斷增加，可能會在預測期內積極推動醫療仿生市場的成長。

各國政府發起的全民健保計畫的廣泛採用以及公共和私人報銷政策覆蓋範圍的擴大預計將推動未來七年人工重要器官和醫療仿生學的使用。

人造重要器官市場包括人工心臟、人造胰臟、人工腎臟和人造肺等產品。這些用於患有器官損傷或完全器官衰竭的患者的器官移植。

2014年，由於高血糖、高血壓、術後感染疾病、腎絲球疾病、損傷和燒燙傷、愛滋病毒等危險因子的日益流行，人工腎臟市場佔據了最大的市場佔有率，超過60%。

人工肝預計在七年的預測期內將以有利的速度成長，是成長最快的產品領域。快速成長的關鍵因素包括慢性阻塞性肺病（COPD）等慢性肺部疾病的盛行率增加以及使用機械人工呼吸器的缺點。

醫學仿生部分包括大腦、耳朵、視覺仿生、外骨骼和仿生肢體等產品。 2014年，由於患有神經系統疾病的患者不斷增加，腦仿生佔據了最大的市場佔有率，約41%。此外，脊髓刺激設備、迷走神經刺激設備和深層腦部刺激器的非侵入性是未來七年對市場成長產生正面影響的主要因素。由於外骨骼的應用範圍廣泛，包括救援、緊急應變、家庭醫療保健和患者康復，對外骨骼的需求可能會激增。

人造重要器官和醫療仿生學市場報告亮點

  • 腦仿生在人工重要器官和醫療仿生市場中佔據主導地位，2023 年收益佔有率為 34.9%。帕金森氏症、憂鬱症和癲癇等神經系統疾病的盛行率不斷上升正在推動市場成長。
  • 2023年銷售佔有率為57.3%，心臟領域佔市場主導地位。這種成長是由於慢性病盛行率的增加、用於移植的心臟的短缺以及外科手術和更強大、更有效的藥物和治療方法的進步。
  • 北美人工重要器官和醫療仿生市場主導全球人工重要器官和醫療仿生市場，2023年銷售佔有率為44.6%。
  • 亞太地區人造重要器官和醫療仿生學市場預計在預測期內成長最快，複合年成長率為 11.1%。由於可支配收入的增加、醫療保健基礎設施的改善和意識的提高，市場將在預測期內呈現成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章：人工重要器官和醫療仿生市場的變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 人工重要器官與醫學仿生市場分析工具
    • 波特的分析
    • PESTEL分析

第4章人工重要器官及醫學仿生市場：人工重要器官預估及趨勢分析

  • 細分儀表板
  • 心
  • 腎
  • 肝
  • 胰臟
  • 肺

第5章人工重要器官與醫學仿生市場：仿生學估計與趨勢分析

  • 細分儀表板
  • 人工重要器官與醫療仿生市場：仿生學波動分析，2023 年及 2030 年
  • 耳仿生學
  • 外骨骼
  • 仿生肢體
  • 腦仿生學
  • 心臟仿生學

第6章人工重要器官與醫學仿生市場：區域估計與趨勢分析

  • 2023年和2030年按地區分類的人工重要器官和醫療仿生市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Medtronic, Inc.
    • LifeNet Health
    • Terumo Corporation
    • Ekso Bionics Holdings, Inc.
    • Nano Retina Ltd.
    • Edwards Lifesciences Corporation
    • InnoScot Health Ltd.
    • Ottobock SE &Co. KGaA
    • Orthofix Medical Inc.
簡介目錄
Product Code: 978-1-68038-546-5

Artificial Vital Organs And Medical Bionics Market Growth & Trends:

The global artificial vital organs and medical bionics market size is expected to reach USD 70.1 billion by 2030, registering a CAGR of 9.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Key growth drivers identified in the artificial vital organs market include increasing base of geriatric population suffering from chronic diseases such as cardiovascular and respiratory diseases leading to organ failures or damage.

Furthermore, the increasing number of patients suffering from physical disabilities such as loss of limbs and arms owing to congenital factors, accidents, serving in armed forces and industrial accidents is likely to positively reinforce medical bionics market growth over the forecast period.

The proliferation of universal health coverage schemes launched by various governments and increasing public and private reimbursement policy coverage are major trends expected to boost the usage rates of artificial vital organs and medical bionics in the next seven years.

The artificial vital organs market includes products such as artificial heart, pancreas, kidneys, and lungs. These are used for organ transplantation in patients suffering with organ damages or complete organ failures.

In 2014, artificial kidney market accounted for the largest market share of over 60% owing to increasing prevalence of high blood sugar, hypertension, post-surgery infections, glomerular diseases, injury or burns, HIV, and other risk factors.

Artificial liver is expected to be the fastest growing product segment growing at a lucrative rate over the forecast period of seven years. Key factors attributing to its rapid growth include increasing prevalence of chronic lung diseases such as COPD and disadvantages of using mechanical ventilators.

The medical bionics segment includes products such as brain, ear, vision bionics, exoskeleton, and bionic limbs. In 2014, brain bionics held the largest market share of nearly 41% due to the continually increasing number of patients suffering from neurological conditions. Furthermore, non-invasive nature of spinal cord stimulators, vagus nerve stimulators, and deep brain stimulators are key factors positively impacting market growth in the next seven years. Exoskeletons are likely to witness a rapid rise in demand owing to its wide applications in rescue, emergency response, home healthcare, and patient rehabilitation.

Artificial Vital Organs And Medical Bionics Market Report Highlights:

  • Brain bionics dominated the artificial vital organs and medical bionics market with a revenue share of 34.9% in 2023. Increased prevalence of neurological conditions such as Parkinson's disease, depression, and epilepsy are driving market growth.
  • The heart segment dominated the market with a revenue share of 57.3% in 2023. This increase is happening due to an increase in the incidence of chronic diseases, scarcity of hearts for transplant, and advancement of the operations and potent effective drugs and treatment.
  • North America artificial vital organs and medical bionics market dominated the global artificial vital organs and medical bionics market with a revenue share of 44.6% in 2023.
  • Asia Pacific artificial vital organs and medical bionics market is expected to the fastest growth in the forecast period with a CAGR of 11.1%. Due to rising disposable income, elevated healthcare infrastructure, and awareness the marketplace is displaying growth within the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Vital Organs and Medical Bionics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Artificial Vital Organs and Medical Bionics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Artificial Vital Organs and Medical Bionics Market: Artificial Organ Estimates & Trend Analysis

  • 4.1. Segment Dashboard
    • 4.1.1. Artificial Vital Organs and Medical Bionics Market: Artificial Organ Movement Analysis, 2023 & 2030 (USD Million)
  • 4.2. Heart
    • 4.2.1. Heart Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Kidney
    • 4.3.1. Kidney Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Liver
    • 4.4.1. Liver Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Pancreas
    • 4.5.1. Pancreas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Lungs
    • 4.6.1. Lungs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Artificial Vital Organs and Medical Bionics Market: Bionics Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Artificial Vital Organs and Medical Bionics Market: Bionics Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Ear Bionics
    • 5.3.1. Ear Bionics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Vision Bionics
    • 5.3.3. Vision Bionics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Exoskeletons
    • 5.4.1. Exoskeletons Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Bionic Limbs
    • 5.5.1. Bionic Limbs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Brain bionics
    • 5.6.1. Brain Bionics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Cardiac Bionics
    • 5.7.1. Cardiac Bionics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Artificial Vital Organs and Medical Bionics Market: Regional Estimates & Trend Analysis

  • 6.1. Artificial Vital Organs and Medical Bionics Market Share, By Region, 2023 & 2030 (USD Billion)
  • 6.2. North America
    • 6.2.1. North America Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Medtronic, Inc.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. LifeNet Health
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. Terumo Corporation
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. Ekso Bionics Holdings, Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. Nano Retina Ltd.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. Edwards Lifesciences Corporation
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. InnoScot Health Ltd.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. Ottobock SE & Co. KGaA
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. Orthofix Medical Inc.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives